Lipid mediators in membrane rafts are important determinants of human health and disease

Applied Physiology, Nutrition and Metabolism

Volumn 32, Issue 3, 2007, Pages 341-350

  Ma, David W L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Caveolae; Lipid rafts; Membrane rafts

Indexed keywords

CHOLESTEROL; FATTY ACID; INSULIN; MEMBRANE LIPID; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE A; PHOSPHOLIPASE D; SPHINGOLIPID;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; CELL MEMBRANE; CHEMISTRY; HUMAN; IMMUNITY; NEOPLASM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; CELL MEMBRANE; CHOLESTEROL; FATTY ACIDS; HUMANS; IMMUNITY; INSULIN; MEMBRANE LIPIDS; NEOPLASMS; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE D; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION; SPHINGOLIPIDS;

EID: 34547459710     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-036     Document Type: Review

References (100)

1. Balbis, A., Baquiran, G., Mounier, C., and Posner, B.I. 2004. Effect of insulin on caveolin-enriched membrane domains in rat liver. J. Biol. Chem. 279: 39348-39357. doi:10.1074/jbc.M404280200. PMID:15252027.
2. Bist, A., Fielding, P.E., and Fielding, C.J. 1997. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc. Natl. Acad. Sci. U.S.A. 94: 10693-10698. doi:10.1073/pnas.94.20.10693. PMID:9380697.
3. Bousserouel, S., Raymondjean, M., Brouillet, A., Bereziat, G., and Andreani, M. 2004. Modulation of cyclin D1 and early growth response factor-1 gene expression in interleukin-1 beta-treated rat smooth muscle cells by n-6 and n-3 polyunsaturated fatty acids. Eur. J. Biochem. 271: 4462-4473. doi:10.1111/j.1432-1033.2004.04385.x. PMID:15560787.
4. Brown, D.A., and London, E. 1998. Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 164: 103-114. doi:10.1007/s002329900397. PMID:9662555.
5. Brown, D.A., and London, E. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275: 17221-17224. doi:10.1074/jbc.R000005200. PMID:10770957.
6. Burgermeister, E., Tencer, L., and Liscovitch, M. 2003. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene, 22: 3888-3900. doi:10.1038/sj.onc.1206625. PMID:12813462.
7. Capozza, P., Williams, T.M., Schubert, W., McClain, S., Bouzahzah, B., Sotgia, F., et al. 2003. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol. 162: 2029-2039. PMID:12759258.
8. Capozza, F., Cohen, A.W., Cheung, M.W., Sotgia, F., Schubert, W., Battista, M., et al. 2005a. Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells. Am. J. Physiol. Cell Physiol. 288: C677-C691. PMID:15548572.
9. Capozza, F., Combs, T.P., Cohen, A.W., Cho, Y.R., Park, S.Y., Schubert, W., et al. 2005b. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am. J. Physiol. Cell Physiol. 288: C1317-C1331. doi:10.1152/ajpcell. 00489.2004. PMID:15689413.
10. Cha, S.H., Jung, N.H., Kim, B.R., Kim, H.W., and Kwak, J.O. 2004. Evidence for cyclooxygenase-1 association with caveolin-1 and -2 in cultured human embryonic kidney (HEK 293) cells. IUBMB Life, 56: 221-227. PMID:15230350.
11. Cohen, A.W., Combs, T.P., Scherer, P.E., and Lisanti, M.P. 2003a. Role of caveolin and caveolae in insulin signaling and diabetes. Am. J. Physiol. Endocrinol. Metab. 285: E1151-E1160. PMID:14607781.
12. Cohen, A.W., Razani, B., Wang, X.B., Combs, T.P., Williams, T.M., Scherer, P.E., et al. 2003b. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am. J. Physiol. Cell Physiol. 285: C222-C235. PMID:12660144.
13. Cohen, A.W., Hnasko, R., Schubert, W., and Lisanti, M.P. 2004. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84: 1341-1379. doi:10.1152/physrev.00046.2003. PMID:15383654.
14. Cordy, J.M., Hussain, I., Dingwall, C., Hooper, N.M., and Turner, A.J. 2003. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 100: 11735-11740. doi:10.1073/pnas.1635130100. PMID:14504402.
15. Czarny, M., Lavie, Y., Fiucci, G., and Liscovitch, M. 1999. Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains. Modulation by caveolin-1 expression and caveolin. J. Biol. Chem. 274: 2717-2724. doi:10.1074/jbc.274.5. 2717. PMID:9915802.
16. de Almeida, R.F., Loura, L.M., Fedorov, A., and Prieto, M. 2005. Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study. J. Mol. Biol. 346: 1109-1120. PMID:15701521.
17. Duncan, R.E., El-Sohemy, A., and Archer, M.C. 2004. Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity. J. Biol. Chem. 279: 33079-33084. doi:10.1074/jbc.M400732200. PMID:15155733.
18. Ehehalt, R., Keller, P., Haass, C., Thiele, C., and Simons, K. 2003. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160: 113-123. doi:10.1083/jcb.200207113. PMID:12515826.
19. Engelman, J.A., Lee, R.J., Karnezis, A., Bearss, D.J., Webster, M., Siegel, P., et al. 1998. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J. Biol. Chem. 273: 20448-20455. doi:10.1074/jbc.273.32. 20448. PMID:9685399.
20. Fan, Y.Y., McMurray, D.N., Ly, L.H., and Chapkin, R.S. 2003. Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J. Nutr. 133: 1913-1920. PMID:12771339.
21. Fan, Y.Y., Ly, L.H., Barhoumi, R., McMurray, D.N., and Chapkin, R.S. 2004. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J. Immunol. 173: 6151-6160. PMID:15528352.
22. Fecchi, K., Volonte, D., Hezel, M.P., Schmeck, K., and Galbiati, F. 2006. Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J. 20: 705-707. PMID:16455755.
23. Feigenson, G.W., and Buboltz, J.T. 2001. Ternary phase diagram of dipalmitoyl-PC/dilauroyl-PC/cholesterol: nanoscopic domain formation driven by cholesterol. Biophys. J. 80: 2775-2788. PMID:11371452.
24. Fiucci, G., Ravid, D., Reich, R., and Liscovitch, M. 2002. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene, 21: 2365-2375. doi:10.1038/sj.onc.1205300. PMID:11948420.
25. Garcia-Cardena, G., Fan, R., Stern, D.F., Liu, J., and Sessa, W.C. 1996a. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271: 27237-27240. PMID:8910295.
26. Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J.E., and Sessa, W.C. 1996b. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. U.S.A. 93: 6448-6453. doi:10. 1073/pnas.93.13.6448. PMID:8692835.
27. Gomez-Mouton, C., Lacalle, R.A., Mira, E., Jimenez-Baranda, S., Barber, D.F., Carrera, A.C., et al. 2004. Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis. J. Cell Biol. 164: 759-768. doi:10.1083/jcb. 200309101. PMID:14981096.
28. Goswami, R., Singh, D., Phillips, G., Kilkus, J., and Dawson, G. 2005. Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines. J. Neurosci. Res. 81: 541-550. doi:10.1002/jnr.20550. PMID:15968641.
29. Graziani, A., Bricko, V., Carmignani, M., Graier, W.F., and Groschner, K. 2004. Cholesterol- and caveolin-rich membrane domains are essential for phospholipase A2-dependent EDHF formation. Cardiovasc. Res. 64: 234-242. doi:10.1016/j. cardiores.2004.06.026. PMID:15485682.
30. Gulbins, E. 2003. Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol. Res. 47: 393-399. doi:10.1016/81043-6618(03)00052- 5. PMID:12676513.
31. Hager, M.H., Solomon, K.R., and Freeman, M.R. 2006. The role of cholesterol in prostate cancer. Curr. Opin. Clin. Nutr. Metab. Care, 9: 379-385. PMID:16778565.
32. Hancock, J.F. 2006. Lipid rafts: contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol. 7: 456-462. doi:10.1038/nrm!925. PMID:16625153.
33. Hayashi, K., Matsuda, S., Machida, K., Yamamoto, T., Fukuda, Y., Nimura, Y., et al. 2001. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61: 2361-2364. PMID:11289096.
34. Hodgkin, M.N., Clark, J.M., Rose, S., Saqib, K., and Wakelam, M.J. 1999. Characterization of the regulation of phospholipase D activity in the detergent-insoluble fraction of HL60 cells by protein kinase C and small G-proteins. Biochem. J. 339: 87-93. doi:10.1042/0264-6021:3390087. PMID:10085231.
35. Hope, H.R., and Pike, L.J. 1996. Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. Mol. Biol. Cell, 7: 843-851. PMID:8816992.
36. Ikezu, T., Trapp, B.D., Song, K.S., Schlegel, A., Lisanti, M.P., and Okamoto, T. 1998. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. J. Biol. Chem. 273: 10485-10495. doi:10.1074/jbc. 273.17.10485. PMID:9553108.
37. Jang, I.H., Kim, J.H., Lee, B.D., Bae, S.S., Park, M.H., Suh, P.G., et al. 2001. Localization of phospholipase C-gammal signaling in caveolae: importance in EGF-induced phosphoinositide hydrolysis but not in tyrosine phosphorylation. FEBS Lett. 491: 4-8. doi:10.1016/S0014-5793(01)02165-2. PMID:11226408.
38. Jin, J.K., Ahn, B.H., Na, Y.J., Kim, J.I., Kim, Y.S., Choi, E.K., et al. 2006. Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease. Neurobiol. Aging, 407: 263-267.
39. Karlsson, M., Thorn, H., Parpal, S., Stralfors, P., and Gustavsson, J. 2002. Insulin induces translocation of glucose transporter GLUT4 to plasma membrane caveolae in adipocytes. FASEB J. 16: 249-251. PMID:11744627.
40. Kawabe, J.I., Grant, B.S., Yamamoto, M., Schwencke, C., Okumura, S., and Ishikawa, Y. 2001. Changes in caveolin subtype protein expression in aging rat organs. Mol. Cell. Endocrinol. 176: 91-95. doi:10.1016/S0303-7207(01) 00472-5. PMID:11369447.
41. Khan, A.H., and Pessin, J.E. 2002. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia, 45: 1475-1483. PMID:12436329.
42. Kusumi, A., Koyama-Honda, I., and Suzuki, K. 2004. Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts. Traffic, 5: 213-230. doi:10.1111/j.1600- 0854.2004.0178.x. PMID:15030563.
43. Kwak, J.O., Lee, W.K., Kim, H.W., Jung, S.M., Oh, K.J., Jung, S.Y., et al. 2006. Evidence for cyclooxygenase-2 association with caveolin-3 in primary cultured rat chondrocytes. J. Korean Med. Sci. 21: 100-106. PMID:16479074.
44. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J.E., Hansen, S.H., et al. 1995. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270: 15693-15701. PMID:7797570.
45. Li, S., Couet, J., and Lisanti, M.P. 1996. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 271: 29182-29190. PMID:8910575.
46. Li, X.A., Everson, W.V., and Smart, E.J. 2005. Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc. Med. 15: 92-96. doi:10.1016/j.tcm.2005.04.001. PMID:16039968.
47. Li, T., Sotgia, F., Vuolo, M.A., Li, M., Yang, W.C., Pestell, R.G., et al. 2006a. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am. J. Pathol. 168: 1998-2013. doi:10.2353/ajpath.2006. 051089. PMID:16723714.
48. Li, Y.C., Park, M.J., Ye, S.K., Kim, C.W., and Kim, Y.N. 2006b. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am. J. Pathol. 168: 1107-1118. doi:10.2353/ajpath.2006.050959. PMID:16565487.
49. Liou, J.Y., Deng, W.G., Gilroy, D.W., Shyue, S.K., and Wu, K.K. 2001. Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J. Biol. Chem. 276: 34975-34982. doi:10.1074/jbc.M105946200. PMID:11432874.
50. Liu, P., and Anderson, R.G. 1995. Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270: 27179-27185. PMID:7592974.
51. Liu, S., Baracos, V.E., Quinney, H.A., and Clandinin, M.T. 1994. Dietary omega-3 and polyunsaturated fatty acids modify fatty acyl composition and insulin binding in skeletal-muscle sarcolemma. Biochem. J. 299: 831-837. PMID:8192673.
52. Liu, P., Rudick, M., and Anderson, R.G. 2002. Multiple functions of caveolin-1. J. Biol. Chem. 277: 41295-41298. doi:10.1074/jbc.R200020200. PMID:12189159.
53. Lopez, J.A., del Conde, I., and Shrimpton, C.N. 2005. Receptors, rafts, and microvesicles in thrombosis and inflammation. J. Thromb. Haemost. 3: 1737-1744. doi:10.1111/j.1538-7836. 2005.01463.x. PMID:16102040.
54. Ma, D.W., Seo, J., Davidson, L.A., Callaway, E.S., Fan, Y.Y., Lupton, J.R., et al. 2004. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J. 18: 1040-1042. PMID:15084525.
55. Macdonald, J.L., and Pike, L.J. 2005. A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res. 46: 1061-1067. PMID:15722565.
56. Martelli, A.M., Faenza, I., Billi, A.M., Manzoli, L., Evangelisti, C., Fala, F., et al. 2006. Intranuclear 3′-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? Cell. Signal. 18: 1101-1107. doi:10.1016/j.cellsig.2006.01.011. PMID:16516442.
57. Martin, S., Phillips, D.C., Szekely-Szucs, K., Elghazi, L., Desmots, F., and Houghton, J.A. 2005. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae. Cancer Res. 65: 11447-11458. doi:10.1158/0008-5472.CAN-05- 1494. PMID:16357153.
58. McDermott, M., Wakelam, M.J., and Morris, A.J. 2004. Phospholipase D. Biochem. Cell Biol. 82: 225-253. doi:10.1139/o03-079. PMID:15052340.
59. Mineo, C., James, G.L., Smart, E.J., and Anderson, R.G. 1996. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J. Biol. Chem. 271: 11930-11935. PMID:8662667.
60. Mineo, C., Anderson, R.G., and White, M.A. 1997. Physical association with ras enhances activation of membrane-bound raf (RafCAAX). J. Biol. Chem. 272: 10345-10348. PMID:9099670.
61. Molander-Melin, M., Blennow, K., Bogdanovic, N., Dellheden, B., Mansson, J.E., and Fredman, P. 2005. Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J. Neurochem. 92: 171-182. doi:10.1111/j.1471-4159.2004.02849. x. PMID:15606906.
62. Nguyen, D.H., Espinoza, J.C., and Taub, D.D. 2004. Cellular cholesterol enrichment impairs T cell activation and chemotaxis. Mech. Ageing Dev. 125: 641-650. doi:10.1016/j.mad.2004.08. 002. PMID:15491683.
63. Oh, Y.S., Cho, K.A., Ryu, S.J., Khil, L.Y., Jun, H.S., Yoon, J.W., et al. 2006. Regulation of insulin response in skeletal muscle cell by caveolin status. J. Cell. Biochem. 99: 747-758. doi:10. 1002/jcb.20943. PMID:16676355.
64. Oka, N., Yamamoto, M., Schwencke, C., Kawabe, J., Ohno, S., Couet, J., et al. 1997. Caveolin interaction with protein kinase c. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J. Biol. Chem. 272: 33416-33421. doi:10.1074/jbc.272.52.33416. PMID:9407137.
65. Oksman, M., Iivonen, H., Hogyes, E., Amtul, Z., Penke, B., Leenders, I., et al. 2006. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis. 23: 563-572. doi:10.1016/j.nbd.2006.04. 013. PMID:16765602.
66. Osaki, M., Oshimura, M., and Ito, H. 2004. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis, 9: 667-676. doi:10.1023/B:APPT.0000045801.15585.dd. PMID:15505410.
67. Palade, G.E. 1953. Fine structure of blood capillaries. J. Appl. Physiol. 24: 1424.
68. Parton, R.G., Hanzal-Bayer, M., and Hancock, J.F. 2006. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 119: 787-796. doi:10.1242/jcs.02853. PMID:16495479.
69. Pike, L.J. 2004. Lipid rafts: heterogeneity on the high seas. Biochem. J. 378: 281-292. doi:10.1042/BJ20031672. PMID:14662007.
70. Pike, L.J. 2006. Rafts defined: a report on the Keystone symposium on lipid rafts and cell function. J. Lipid Res. 47: 1597-1598. PMID:16645198.
71. Pike, L.J., and Casey, L. 1996. Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J. Biol. Chem. 271: 26453-26456. PMID:8900109.
72. Pike, L.J., Han, X., Chung, K.N., and Gross, R.W. 2002. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry, 41: 2075-2088. doi:10.1021/bi0156557. PMID:11827555.
73. Prior, I.A., and Hancock, J.F. 2001. Compartmentalization of Ras proteins. J. Cell Sci. 114: 1603-1608. PMID:11309191.
74. Prior, I.A., Harding, A., Van, J., Sluimer, J., Parton, R.G., and Hancock, J.F. 2001. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat. Cell Biol. 3: 368-375. doi: 10.1038/35070050. PMID:11283610.
75. Sagara, Y., Mimori, K., Yoshinaga, K., Tanaka, F., Nishida, K., Ohno, S., et al. 2004. Clinical significance of caveolin-1, c aveolin-2 and HER2/neu mRNA expression in human breast cancer. Br. J. Cancer, 91: 959-965. PMID:15305200.
76. Schaffner, C.P. 1981. Prostatic cholesterol metabolism: regulation and alteration. Prog. Clin. Biol. Res. 75A: 279-324. PMID.-6175978.
77. Shenoy-Scaria, A.M., Gauen, L.K., Kwong, J., Shaw, A.S., and Lublin, D.M. 1993. Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p561ck and p59fyn mediates interaction with glycosyl- phosphatidylinositol-anchored proteins. Mol. Cell. Biol. 13: 6385-6392. PMID:8413237.
78. Shogomori, H., and Brown, D.A. 2003. Use of detergents to study membrane rafts: the good, the bad, and the ugly. Biol. Chem. 384: 1259-1263. doi:10.1515/BC.2003.139. PMID:14515986.
79. Simons, K., and Ehehalt, R. 2002. Cholesterol, lipid rafts, and disease. J. Clin. Invest. 110: 597-603. doi: 10.1172/JCI200216390. PMID:12208858.
80. Simons, K., and Toomre, D. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1: 31-39. doi: 10.1038/35036052. PMID:11413487.
81. Sitrin, R.G., Emery, S.L., Sassanella, T.M., Blackwood, R.A., and Petty, H.R. 2006. Selective localization of recognition complexes for leukotriene B4 and formyl-Met-Leu-Phe within lipid raft microdomains of human polymorphonuclear neutrophils. J. Immunot. 177: 8177-8184. PMID:17114494.
82. Sloan, E.K., Stanley, K.L., and Anderson, R.L. 2004. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene, 23: 7893-7897. doi:10.1038/sj.onc.1208062. PMID:15334058.
83. Smart, E.J., Ying, Y.S., Mineo, C., and Anderson, R.G. 1995. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc. Natl. Acad. Sci. U.S.A. 92: 10104-10108. doi:10.1073/pnas.92.22. 10104. PMID:7479734.
84. Smart, E.J., Graf, G.A., McNiven, M.A., Sessa, W.C., Engelman, J.A., Scherer, P.E., et al. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19: 7289-7304. PMID:10523618.
85. Stirewalt, D.L., Appelbaum, F.R., Willman, C.L., Zager, R.A., and Banker, D.E. 2003. Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression. Leuk. Res. 27: 133-145. doi: 10.1016/80145-2126(02) 00085-1. PMID:12526919.
86. Stulnig, T.M., Berger, M., Sigmund, T., Raederstorff, D., Stockinger, H., and Waldhausl, W. 1998. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J. Cell Biol. 143: 637-644. doi: 10.1083/jcb.143.3.637. PMID:9813086.
87. Stulnig, T.M., Huber, J., Leitinger, N., Imre, E.M., Angelisova, P., Nowotny, P., et al. 2001. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J. Biol. Chem. 276: 37335-37340. doi: 10.1074/jbc.M106193200. PMID:11489905.
88. Tahir, S.A., Yang, G., Ebara, S., Timme, T.L., Satoh, T., Li, L., et al. 2001. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res. 61: 3882-3885. PMID:11358800.
89. Torres, V.A., Tapia, J.C., Rodriguez, D.A., Parraga, M., Lisboa, P., Montoya, M., et al. 2006. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J. Cell Sci. 119: 1812-1823. doi:10. 1242/jcs.02894. PMID:16608879.
90. van Buul, J.D., Voermans, C., van Gelderen, J., Anthony, E.C., van der School, C.E., and Hordijk, P.L. 2003. Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4. J. Biol. Chem. 278: 30302-30310. doi:10.1074/jbc. M304764200. PMID:12766157.
91. Villalba, M., Bi, K., Hu, J., Altman, Y., Bushway, P., Reits, E., et al. 2002. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 157: 253-263. doi:10.1083/jcb.200201097. PMID:11956228.
92. Williams, T.M., and Lisanti, M.P. 2005. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288: C494-C506. PMID:15692148.
93. Williams, T.M., Cheung, M.W., Park, D.S., Razani, B., Cohen, A.W., Muller, W.J., et al. 2003. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol. Biol. Cell, 14: 1027-1042. doi:10.1091/mbc.E02-08-0503. PMID:12631721.
94. Williams, T.M., Medina, F., Badano, I., Kazan, R.B., Hutchinson, J., Muller, W.J., et al. 2004. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J. Biol. Chem. 279: 51630-51646. doi:10.1074/jbc.M409214200. PMID:15355971.
95. Wu, M., Harvey, K.A., Ruzmetov, N., Welch, Z.R., Sech, L., Jackson, K., et al. 2005. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int. J. Cancer, 117: 340-348. doi:10.1002/ijc.21238. PMID:15900589.
96. Yamada, E. 1955. The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1: 445-458. PMID:13263332.
97. Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M.P., Myers, M.G., Jr., and Ishikawa, Y. 1998. Caveolin is an activator of insulin receptor signaling. J. Biol. Chem. 273: 26962-26968. doi: 10.1074/jbc.273.41.26962. PMID:9756945.
98. Zeyda, M., Staffler, G., Horejsi, V., Waldhausl, W., and Stulnig, T.M. 2002. LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty acids. J. Biol. Chem. 277: 28418-28423. doi: 10.1074/jbc.M203343200. PMID:12029091.
99. Zhang, W., Trible, R.P., and Samelson, L.E. 1998. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity, 9: 239-246. doi:10.1016/S1074- 7613(00)80606-8. PMID:9729044.
100. Zhuang, L., Kim, J., Adam, R.M., Solomon, K.R., and Freeman, M.R. 2005. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J. Clin. Invest. 115: 959-968. doi: 10.1172/JCI200519935. PMID:15776112.